Reuters logo
BRIEF-Verastem says ‍plans to submit NDA for duvelisib during Q1 of 2018​
2017年10月31日 / 上午11点17分 / 21 天前

BRIEF-Verastem says ‍plans to submit NDA for duvelisib during Q1 of 2018​

Oct 31 (Reuters) - Verastem Inc-

* Verastem announces regulatory strategy for duvelisib, new drug application following guidance from FDA

* Verastem Inc - ‍plans to submit NDA for duvelisib during Q1 of 2018​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below